Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (241-250 of 367) with videos related to

Pageof 37
Sort By:
The Lancet. Oncology|December 15, 2010
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialJack Cuzick, Ivana Sestak, Sarah E Pinder, et al.
Cancer|November 15, 2007
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intentMichael W Kattan, Jack Cuzick, Gabrielle Fisher, et al.
Breast Cancer Research : BCR|March 16, 2012
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancerIsabel Pinhel, Margaret Hills, Suzanne Drury, et al.
Lancet (London, England)|May 1, 2010
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialWendy S Atkin, Rob Edwards, Ines Kralj-Hans, et al.
British Journal of Cancer|June 9, 2020
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)Maria Kyrgiou, Marc Arbyn, Christine Bergeron, et al.
BJU International|February 26, 2009
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancerSak Kudahetti, Gabrielle Fisher, Laurence Ambroisine, et al.
JCO Precision Oncology|September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical TrialAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2026
Evaluation of the Quality and Suitability of Self-Collected Vaginal and Urine Samples for Human Papillomavirus Testing: A Prospective Matched StudyKim Chu, Sofia Vidali, Anna Parberry, et al.
The Lancet. Oncology|March 29, 2011
Preventive therapy for breast cancer: a consensus statementJack Cuzick, Andrea DeCensi, Banu Arun, et al.
Pageof 37

Showing results (241-250 of 367) with videos related to

Sort By:
Pageof 37
The Lancet. Oncology|December 15, 2010
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialJack Cuzick, Ivana Sestak, Sarah E Pinder, et al.
Cancer|November 15, 2007
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intentMichael W Kattan, Jack Cuzick, Gabrielle Fisher, et al.
Breast Cancer Research : BCR|March 16, 2012
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancerIsabel Pinhel, Margaret Hills, Suzanne Drury, et al.
Lancet (London, England)|May 1, 2010
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialWendy S Atkin, Rob Edwards, Ines Kralj-Hans, et al.
British Journal of Cancer|June 9, 2020
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)Maria Kyrgiou, Marc Arbyn, Christine Bergeron, et al.
BJU International|February 26, 2009
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancerSak Kudahetti, Gabrielle Fisher, Laurence Ambroisine, et al.
JCO Precision Oncology|September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical TrialAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2026
Evaluation of the Quality and Suitability of Self-Collected Vaginal and Urine Samples for Human Papillomavirus Testing: A Prospective Matched StudyKim Chu, Sofia Vidali, Anna Parberry, et al.
The Lancet. Oncology|March 29, 2011
Preventive therapy for breast cancer: a consensus statementJack Cuzick, Andrea DeCensi, Banu Arun, et al.
Pageof 37